|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of sales | |||||
| Selling, general and administrative expenses | |||||
| Research and development expenses | |||||
| Amortization and impairment losses on intangible assets associated with products | |||||
| Other operating income | |||||
| Other operating expenses | |||||
| Operating profit | |||||
| Finance income | |||||
| Finance expenses | |||||
| Share of profit (loss) of investments accounted for using the equity method | |||||
| Profit (loss) before tax | |||||
| Income tax (expenses) benefit | |||||
| Net profit (loss) for the year | |||||
| Earnings per share (JPY) | |||||
| Basic earnings (loss) per share (in JPY per share) | |||||
| Diluted earnings (loss) per share (in JPY per share) | |||||
| Attributable to: | |||||
| Owners of the Company | |||||
| Non-controlling interests |
Loading...
